(Q38926381)

1 July 2019

title

Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses (English)

1 reference

1 July 2019

0 references

1 reference

3

1 reference

1 July 2019

Stuart T. Nichol

6

object named as

Stuart T Nichol

1 reference

1 July 2019

7

Jonathan S Towner

1 reference

1 July 2019

author name string

César G Albariño

1

1 reference

1 July 2019

Lisa Wiggleton Guerrero

2

1 reference

1 July 2019

Luke S Uebelhoer

4

1 reference

1 July 2019

Ayan K Chakrabarti

5

1 reference

1 July 2019

language of work or name

English

0 references

publication date

19 December 2014

1 reference

1 July 2019

published in

Virology

1 reference

1 July 2019

volume

476

1 reference

1 July 2019

page(s)

85-91

1 reference

1 July 2019

Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Differential recognition of viral RNA by RIG-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebola and marburg hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Structure of the Ebola VP35 interferon inhibitory domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Using next generation sequencing to identify yellow fever virus in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Discovery of an ebolavirus-like filovirus in europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Structural basis for Marburg virus VP35-mediated immune evasion mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Filoviral immune evasion mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Marburg virus VP40 antagonizes interferon signaling in a species-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.12.002

Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25531184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2014.12.002

1 reference

1 July 2019

PMC publication ID

6461211

1 reference

1 July 2019

PubMed publication ID

25531184

1 reference

1 July 2019